🔴 HCW Biologics is trading 7.13% down in pre-market as no verified catalyst was identified

HCW Biologics is trading 7.13% down at $2.73 with no verified September 8, 2026 company-specific catalyst identified.

• The latest confirmed announcement was a September 2, 2026 patent allowance for HCW9302’s alopecia areata treatment claims, which does not directly explain the decline.
• Broader markets are mixed: S&P 500 down 0.13%, Nasdaq up 0.26%, and Dow down 0.63%.
• The movement’s cause remains unclear.